OQS
RMD icon

Occudo Quantitative Strategies’s ResMed RMD Stock Holding History

Occudo Quantitative Strategies’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.11M Buy
41,636
+28,641
+220% +$5.94M 0.43% 59
2026
Q1 		$2.78M Buy
12,995
+7,709
+146% +$1.92M 0.15% 205
2025
Q4 		$1.27M Buy
5,286
+264
+5% +$67.5K 0.09% 275
2025
Q3 		$1.37M Buy
5,022
+3,749
+295% +$1.02M 0.17% 175
2025
Q2 		$328K Sell
1,273
-3,302
-72% -$788K 0.04% 444
2025
Q1 		$1.01M Buy
4,575
+1,768
+63% +$413K 0.13% 223
2024
Q4 		$642K Buy
+2,807
New +$676K 0.12% 253
2024
Q2 		– Sell
-3,481
Closed -$689K – 957
2024
Q1 		$689K Sell
3,481
-7,090
-67% -$1.3M 0.12% 241
2023
Q4 		$1.82M Buy
10,571
+1,519
+17% +$233K 0.25% 108
2023
Q3 		$1.34M Buy
9,052
+6,727
+289% +$1.22M 0.17% 181
2023
Q2 		$508K Buy
+2,325
New +$518K 0.05% 554
2021
Q2 		– Sell
-4,885
Closed -$948K – 1025
2021
Q1 		$948K Buy
+4,885
New +$980K 0.21% 141

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Occudo Quantitative Strategies's RMD Position: Q2 2026 in Review

Occudo Quantitative Strategies increased its ResMed (RMD) stake by 220% in Q2 2026, buying an estimated $5.94M and bringing the position to 41,636 shares worth $8.11M. The position accounts for 0.43% of the portfolio, ranked #59.

Occudo Quantitative Strategies first reported a position in RMD in Q1 2021 and has held it in 12 quarters since. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Occudo Quantitative Strategies held 41,636 shares of ResMed worth $8.11M as of Q2 2026.
  • Occudo Quantitative Strategies bought 28,641 ResMed shares in Q2 2026, an estimated $5.94M.
  • ResMed made up 0.43% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #59 holding.
  • Occudo Quantitative Strategies first reported a position in ResMed in Q1 2021 and has held it in 12 quarters since.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.